HomeMEHCQ • OTCMKTS
add
23andMe Holding Co
Previous close
$4.24
Day range
$4.05 - $4.39
Year range
$0.47 - $10.81
Market cap
117.60M USD
Avg Volume
575.71K
P/E ratio
-
Dividend yield
-
Primary exchange
OTCMKTS
In the news
Financials
Income Statement
Revenue
Net income
(USD) | Mar 2025info | Y/Y change |
---|---|---|
Revenue | 45.15M | -29.49% |
Operating expense | 65.51M | -34.62% |
Net income | -99.35M | 52.43% |
Net profit margin | -220.04 | 32.54% |
Earnings per share | — | — |
EBITDA | -45.06M | 35.08% |
Effective tax rate | 0.00% | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Mar 2025info | Y/Y change |
---|---|---|
Cash and short-term investments | 38.25M | -82.33% |
Total assets | 159.89M | -59.54% |
Total liabilities | 186.64M | -9.68% |
Total equity | -26.74M | — |
Shares outstanding | 27.54M | — |
Price to book | -4.37 | — |
Return on assets | -54.88% | — |
Return on capital | -230.70% | — |
Cash Flow
Net change in cash
(USD) | Mar 2025info | Y/Y change |
---|---|---|
Net income | -99.35M | 52.43% |
Cash from operations | -40.73M | -57.97% |
Cash from investing | -734.00K | 65.80% |
Cash from financing | -529.00K | -126.45% |
Net change in cash | -41.99M | -61.95% |
Free cash flow | -82.91M | -285.64% |
About
23andMe Holding Co. is an American personal genomics and biotechnology company based in South San Francisco, California. It is best known for providing a direct-to-consumer genetic testing service in which customers provide a saliva sample that is laboratory analysed, using single nucleotide polymorphism genotyping, to generate reports relating to the customer's ancestry and genetic predispositions to health-related topics. The company's name is derived from the 23 pairs of chromosomes in a diploid human cell.
Founded in 2006, 23andMe soon became the first company to begin offering autosomal DNA testing for ancestry, which all other major companies now use. Its saliva-based direct-to-consumer genetic testing business was named "Invention of the Year" by Time in 2008.
The company had a previously fraught relationship with the United States Food and Drug Administration due to its genetic health tests; as of October 2015, DNA tests ordered in the US include a revised health component, per FDA approval. 23andMe has been selling a product with both ancestry and health-related components in Canada since October 2014, and in the UK since December 2014. Wikipedia
Founded
Apr 2006
Headquarters
Website
Employees
261